Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Bertil Damato will oversee the provision of clinical care to patients with an ocular tumour and develop a research group to focus on ocular melanoma and other eye tumours.

Bertil Damato

Bertil Damato has extensive experience in the ocular oncology field, both in the UK and the US. His achievements include several enhancements in the treatment for ocular melanoma and in survival prognostication by multivariate analysis of genetic aberrations and as well as anatomic and histological predictors. He has also conducted research on quality of life after treatment of intraocular melanoma and has been heavily involved in education aimed at improving the detection and diagnosis of patients with an ocular tumour.

One of the priorities of the Oxford Ocular Oncology Research Group is to devise and evaluate novel methods for educating optometrists and general ophthalmologists on ocular tumour diagnosis, also exploring any opportunities for harnessing advances in artificial intelligence.  



Similar stories

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Obituary: Carol Holder

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.